noad

Vascular Solutions News (NASDAQ:VASC)

Latest Vascular Solutions News Headlines
DateTimeSource
Headline
06/03/20088:00AMPRNUSVNUS Announces Settlement of Patent Litigation with AngioDynamics and Vascular Solutions
SAN JOSE, Calif., June 3 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (NASDAQ:VNUS) today announced that it has entered into an Agreement with AngioDynamics (NASDAQ:ANGO) and Vascular Solutions (NASDAQ:VASC) that settles and resolves the patent infringement lawsuit between the companies filed in 2005... More...>>
01/29/20074:05PMPRNUSVascular Solutions Announces Fourth Quarter Net Sales up 30% to Record $11.5 Million
MINNEAPOLIS, Jan. 29 /PRNewswire-FirstCall/ -- Vascular Solutions, Inc. (NASDAQ:VASC) today announced financial results for the fourth quarter ended December 31, 2006. Highlights of the fourth quarter and other recent events include: -- Achieved record net sales of $11.5 million, up 30% over $8.9 million... More...>>
01/22/20074:05PMPRNUSVascular Solutions Announces 510(K) Clearance of New 023 Version of the Twin- Pass Dual Access Catheter
MINNEAPOLIS, Jan. 22 /PRNewswire-FirstCall/ -- Vascular Solutions, Inc. (NASDAQ:VASC) today announced that it has received 510(k) clearance from the U.S. Food & Drug Administration to launch the new 023 version of its Twin- Pass(R) dual access catheter. The original Twin-Pass catheter was launched in January 2006 as... More...>>
01/10/20074:05PMPRNUSVascular Solutions, Inc. to Webcast Fourth Quarter Conference Call Monday, January 29, 2007 at 3:30pm CST
MINNEAPOLIS, Jan. 10 /PRNewswire-FirstCall/ -- Vascular Solutions, Inc. (NASDAQ:VASC), today announced that it will host a live Webcast of its fourth quarter conference call on Monday, January 29, 2007 at 3:30pm CST. Vascular Solutions' Chief Executive Officer, Howard Root, and Chief Financial Officer, James Hennen... More...>>
01/09/20074:05PMPRNUSKing Pharmaceuticals Acquires License From Vascular Solutions to Hemostatic Products Containing King's THROMBIN-JMI(R)
BRISTOL, Tenn. and MINNEAPOLIS, Jan. 9 /PRNewswire-FirstCall/ -- King Pharmaceuticals, Inc. (NYSE:KG) and Vascular Solutions, Inc. (NASDAQ:VASC) announced today that the companies have entered into a series of agreements relating to Vascular Solutions' hemostatic products. Pursuant to the agreements, Vascular Solutions... More...>>
01/08/20074:05PMPRNUSVascular Solutions Announces 510(K) Clearance of InnerChange Micro-Introducer Catheter
MINNEAPOLIS, Jan. 8 /PRNewswire-FirstCall/ -- Vascular Solutions, Inc. (NASDAQ:VASC) today announced that it has received 510(k) clearance from the U.S. Food & Drug Administration to launch the InnerChange(TM) micro-introducer catheter. The InnerChange is a kit of custom designed components that allows a physician... More...>>
01/08/20074:05PMPRNUSVascular Solutions Announces 510(K) Clearance of InnerChange Micro-Introducer Catheter
MINNEAPOLIS, Jan. 8 /PRNewswire-FirstCall/ -- Vascular Solutions, Inc. (NASDAQ:VASC) today announced that it has received 510(k) clearance from the U.S. Food & Drug Administration to launch the InnerChange(TM) micro-introducer catheter. The InnerChange is a kit of custom designed components that allows a physician... More...>>
12/26/20064:05PMPRNUSVascular Solutions Announces Approval of 'Pocket Protector' Indication for D-Stat Flowable Hemostat
MINNEAPOLIS, Dec. 26 /PRNewswire-FirstCall/ -- Vascular Solutions, Inc. (NASDAQ:VASC) today announced that it has received approval from the United States Food & Drug Administration (FDA) of its PMA Supplement for the added indication for the use of the D-Stat(R) Flowable hemostat for the reduction in the incidence... More...>>
12/06/20064:05PMPRNUSVascular Solutions to Participate in RBC Capital Markets 2006 Health Care Conference
MINNEAPOLIS, Dec. 6 /PRNewswire-FirstCall/ -- Vascular Solutions, Inc. (NASDAQ:VASC) today announced that the Company is scheduled to participate in the RBC Capital Markets 2006 Health Care Conference being held next week at the Westin New York Times Square Hotel in New York City. Howard Root, Chief Executive Officer... More...>>
10/19/20064:05PMPRNUSVascular Solutions Announces Third Quarter Net Sales Up 28% to Record $11 Million
MINNEAPOLIS, Oct. 19 /PRNewswire-FirstCall/ -- Vascular Solutions, Inc. (NASDAQ:VASC) today announced record revenue for the third quarter ended September 30, 2006 of $11.0 million, a 28% increase over the $8.6 million recorded in the third quarter of 2005. The third quarter of 2006 represented the company's eleventh... More...>>
10/19/20069:26AMPRNUSVascular Solutions Announces Key Presentations at Transcatheter Cardiovascular Therapeutics Meeting in Washington D.C.
Scientific presentations on D-Stat Dry hemostatic bandage and Pronto extraction catheter MINNEAPOLIS, Oct. 19 /PRNewswire-FirstCall/ -- Vascular Solutions, Inc. (NASDAQ:VASC) today announced the schedule of significant scientific presentations to occur at the annual Transcatheter Cardiovascular Therapeutics (TCT) 18th... More...>>
10/11/20064:05PMPRNUSVascular Solutions Announces Expanded Indications For D-Stat Dry Hemostatic Bandage
50% Reduction in Time-to-Hemostasis Supported by Randomized 376-Patient Clinical Study MINNEAPOLIS, Oct. 11 /PRNewswire-FirstCall/ -- Vascular Solutions, Inc. (NASDAQ:VASC) today announced that it has received clearance from the U.S. FDA of an expanded indication for its D-Stat Dry hemostatic bandage. As a result of... More...>>
09/29/20064:05PMPRNUSVascular Solutions, Inc. to Webcast Third Quarter Conference Call Thursday, October 19, 2006 at 3:30pm CST
MINNEAPOLIS, Sept. 29 /PRNewswire-FirstCall/ -- Vascular Solutions, Inc. (NASDAQ:VASC), today announced that it will host a live Webcast of its third quarter conference call on Thursday, October 19, 2006 at 3:30pm CST. Vascular Solutions' Chief Executive Officer, Howard Root, and Chief Financial Officer, James Hennen... More...>>
09/21/20064:05PMPRNUSVascular Solutions to Present at UBS Global Life Sciences Conference
MINNEAPOLIS, Sept. 21 /PRNewswire-FirstCall/ -- Vascular Solutions, Inc. (NASDAQ:VASC) today announced that the Company is scheduled to present at the UBS Global Life Sciences Conference on Thursday, September 28, 2006 at 10:30am (EDT). Howard Root, Chief Executive Officer of Vascular Solutions, will deliver the Company's... More...>>
08/31/20062:04PMPRNUSVascular Solutions Comments on Summary Judgment Decision in Diomed Intellectual Property Litigation
MINNEAPOLIS, Aug. 31 /PRNewswire-FirstCall/ -- Vascular Solutions, Inc. (NASDAQ:VASC) today commented on the decision of the U.S. District Court entered yesterday concerning motions for summary judgment in its pending patent litigation with Diomed Holdings, Inc. Howard Root, CEO of Vascular Solutions, commented: "The... More...>>
08/28/20064:05PMPRNUSVascular Solutions to Present at Thomas Weisel Partners Healthcare Conference 2006
MINNEAPOLIS, Aug. 28 /PRNewswire-FirstCall/ -- Vascular Solutions, Inc. (NASDAQ:VASC) today announced that the Company is scheduled to present at the Thomas Weisel Partners Healthcare Conference 2006 on Friday, September 8, 2006 at 9:10am (EDT). Howard Root, Chief Executive Officer of Vascular Solutions, will deliver... More...>>
07/27/20064:05PMPRNUSVascular Solutions to Present at Canaccord Adams 2006 Summer Seminar
MINNEAPOLIS, July 27 /PRNewswire-FirstCall/ -- Vascular Solutions, Inc. (NASDAQ:VASC) today announced that the Company is scheduled to present at the Canaccord Adams 2006 Summer Seminar on Wednesday, August 9, 2006 at 10:00am (EST). Howard Root, Chief Executive Officer of Vascular Solutions, will deliver the Company's... More...>>
07/20/20064:05PMPRNUSVascular Solutions Announces Second Quarter Net Sales Up 35% to Record $10.9 Million and Raises 2006 Guidance
Each major product line contributed to 10% sequential quarterly sales growth MINNEAPOLIS, July 20 /PRNewswire-FirstCall/ -- Vascular Solutions, Inc. (NASDAQ:VASC) today announced record revenue for the second quarter ended June 30, 2006 of $10.9 million, a 35% increase over the $8.1 million recorded in the second quarter... More...>>
06/28/20064:05PMPRNUSVascular Solutions, Inc. to Webcast Second Quarter Conference Call Thursday, July 20, 2006 at 3:30pm CST
MINNEAPOLIS, June 28 /PRNewswire-FirstCall/ -- Vascular Solutions, Inc. (NASDAQ:VASC), today announced that it will host a live Webcast of its second quarter conference call on Thursday, July 20, 2006 at 3:30pm CST. Vascular Solutions' Chief Executive Officer, Howard Root, and Chief Financial Officer, James Hennen... More...>>
06/23/20064:04PMPRNUSVascular Solutions and Diomed Settle Trade Secret and Sheath Marking Litigation
MINNEAPOLIS, June 23 /PRNewswire-FirstCall/ -- Vascular Solutions, Inc. (NASDAQ:VASC) and Diomed, Inc., a subsidiary of Diomed Holdings, Inc. (AMEX:DIO) today jointly announced that they have settled the trademark and trade secret litigation between the parties and all issues surrounding Diomed's marked sheath patents... More...>>


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
37 site:2us nasdaq vasc081122 10:56 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )